SPRINGWORKS THERAPEUTICS, INC. (SWTX): Price and Financial Metrics
SWTX Price/Volume Stats
| Current price | $37.44 | 52-week high | $53.92 |
| Prev. close | $37.93 | 52-week low | $20.19 |
| Day low | $36.74 | Volume | 1,181,700 |
| Day high | $38.58 | Avg. volume | 998,408 |
| 50-day MA | $32.57 | Dividend yield | N/A |
| 200-day MA | $40.01 | Market Cap | 2.79B |
SWTX Stock Price Chart Interactive Chart >
SPRINGWORKS THERAPEUTICS, INC. (SWTX) Company Bio
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
SWTX Price Returns
| 1-mo | 25.66% |
| 3-mo | -9.02% |
| 6-mo | -11.66% |
| 1-year | 80.78% |
| 3-year | -44.92% |
| 5-year | 88.14% |
| YTD | 2.58% |
| 2023 | 40.33% |
| 2022 | -58.03% |
| 2021 | -14.53% |
| 2020 | 88.41% |
| 2019 | N/A |
Loading social stream, please wait...